Hiroomi Kanayama Selected Research

Anticoagulants

1/2022

Retroperitoneal hemorrhage in a patient with coronavirus disease 2019 (COVID-19):A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroomi Kanayama Research Topics

Disease

9	Renal Cell Carcinoma (Grawitz Tumor) 03/2023 - 07/2007
8	Neoplasms (Cancer) 01/2023 - 12/2007
6	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 03/2011
5	Neoplasm Metastasis (Metastasis) 04/2022 - 02/2010
5	Urinary Bladder Neoplasms (Bladder Cancer) 03/2017 - 04/2008
3	Carcinoma (Carcinomatosis) 02/2022 - 05/2016
2	Margins of Excision 01/2023 - 01/2021
2	Pain (Aches) 10/2017 - 11/2015
2	Diarrhea 10/2017 - 06/2013
1	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 11/2022
1	Ureteral Obstruction 05/2022
1	COVID-19 01/2022
1	Anus Neoplasms (Anal Cancer) 01/2022
1	Urinary Bladder Fistula (Vesical Fistula) 01/2022
1	Fistula 01/2022
1	Hemorrhage 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Intraoperative Complications 01/2021
1	Disease Progression 11/2020
1	Thrombosis (Thrombus) 05/2018
1	Liposarcoma 05/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2017
1	Fever (Fevers) 10/2017
1	Hematuria 10/2017
1	Cystitis 10/2017
1	Hypothyroidism 06/2013
1	Stomatitis 06/2013
1	Dysphonia (Spastic Dysphonia) 06/2013
1	Hypertension (High Blood Pressure) 06/2013
1	Hand-Foot Syndrome 06/2013
1	Anemia 09/2012
1	Solitary Kidney 07/2010

Drug/Important Bio-Agent (IBA)

3	cabozantinibIBA 03/2023 - 03/2017
3	Axitinib (AG 013736)IBA 01/2023 - 06/2013
3	Messenger RNA (mRNA)IBA 09/2013 - 02/2010
2	Tyrosine Kinase InhibitorsIBA 03/2023 - 11/2020
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2023 - 06/2013
2	NivolumabIBA 04/2022 - 10/2017
2	CytokinesIBA 12/2014 - 12/2007
2	AndrogensIBA 09/2013 - 06/2011
2	Thymidylate SynthaseIBA 09/2013 - 03/2011
2	Sorafenib (BAY 43-9006)FDA Link 06/2013 - 07/2010
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 02/2010
2	Fluorouracil (Carac)FDA LinkGeneric 06/2011 - 03/2011
1	Biomarkers (Surrogate Marker)IBA 03/2023
1	Insulin ReceptorIBA 01/2023
1	4-azidosalicylic acid-phosphatidylserineIBA 11/2022
1	IpilimumabIBA 04/2022
1	PlatinumIBA 02/2022
1	avelumabIBA 02/2022
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Carcinoembryonic AntigenIBA 01/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 04/2021
1	Capsules (Microcapsules)IBA 04/2021
1	SteroidsIBA 10/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2017
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 03/2017
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 03/2017
1	Docetaxel (Taxotere)FDA Link 08/2015
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2014
1	EnzymesIBA 09/2013
1	TegafurIBA 09/2013
1	Thymidine PhosphorylaseIBA 09/2013
1	UracilIBA 09/2013
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 09/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2012
1	PlakophilinsIBA 01/2012
1	Insulin-Like PeptidesIBA 06/2011
1	Insulin-Like Growth Factor Binding Protein 3IBA 06/2011
1	Hormones (Hormone)IBA 03/2011
1	Androgen Receptors (Androgen Receptor)IBA 03/2011
1	hydroxyflutamideIBA 03/2011
1	bicalutamide (Casodex)FDA LinkGeneric 03/2011
1	Sunitinib (Sutent)FDA Link 07/2010
1	Microfilament Proteins (Actin Binding Proteins)IBA 02/2010
1	RNA (Ribonucleic Acid)IBA 02/2010

Therapy/Procedure

11	Therapeutics 03/2023 - 04/2008
5	Nephrectomy 01/2023 - 07/2010
4	Drug Therapy (Chemotherapy) 02/2022 - 04/2008
3	Castration 08/2015 - 06/2011
2	Warm Ischemia 01/2023 - 01/2021
2	Neoadjuvant Therapy 11/2022 - 07/2010
1	Length of Stay 01/2023
1	Sutures (Suture) 01/2023
1	Replantation 11/2022
1	Prostatectomy (Retropubic Prostatectomy) 10/2022
1	Stents 05/2022
1	Lasers (Laser) 05/2022
1	Conservative Treatment 01/2022
1	Blood Transfusion (Blood Transfusions) 01/2022
1	Colostomy 01/2022
1	Pelvic Exenteration 01/2022
1	Urinary Diversion (Ileal Conduit) 01/2022
1	Minimally Invasive Surgical Procedures 01/2022
1	Surgical Instruments (Clip) 01/2021
1	Molecular Targeted Therapy 07/2010
1	Radiotherapy 04/2008
1	Cystectomy 04/2008